title: Are pharmaceuticals with evolutionary conserved molecular drug targets more potent to cause toxic effects in non-target organisms?
abstract: The ubiquitous use of pharmaceuticals has resulted in a continuous discharge into wastewater and pharmaceuticals and their metabolites are found in the environment. Due to their design towards specific drug targets, pharmaceuticals may be therapeutically active already at low environmental concentrations. Several human drug targets are evolutionary conserved in aquatic organisms, raising concerns about effects of these pharmaceuticals in non-target organisms. In this study, we hypothesized that the toxicity of a pharmaceutical towards a non-target invertebrate depends on the presence of the human drug target orthologs in this species. This was tested by assessing toxicity of pharmaceuticals with (miconazole and promethazine) and without (levonorgestrel) identified drug target orthologs in the cladoceran Daphnia magna. The toxicity was evaluated using general toxicity endpoints at individual (immobility, reproduction and development), biochemical (RNA and DNA content) and molecular (gene expression) levels. The results provide evidence for higher toxicity of miconazole and promethazine, i.e. the drugs with identified drug target orthologs. At the individual level, miconazole had the lowest effect concentrations for immobility and reproduction (0.3 and 0.022 mg L-1, respectively) followed by promethazine (1.6 and 0.18 mg L-1, respectively). At the biochemical level, individual RNA content was affected by miconazole and promethazine already at 0.0023 and 0.059 mg L-1, respectively. At the molecular level, gene expression for cuticle protein was significantly suppressed by exposure to both miconazole and promethazine; moreover, daphnids exposed to miconazole had significantly lower vitellogenin expression. Levonorgestrel did not have any effects on any endpoints in the concentrations tested. These results highlight the importance of considering drug target conservation in environmental risk assessments of pharmaceuticals.
authors.affiliation: Department of Applied Environmental Science, Stockholm University, Stockholm, Sweden.
authors.forename: Sara
authors.initials: S
authors.lastname: Furuhagen
authors.affiliation: Department of Applied Environmental Science, Stockholm University, Stockholm, Sweden.
authors.forename: Anne
authors.initials: A
authors.lastname: Fuchs
authors.affiliation: Department of Applied Environmental Science, Stockholm University, Stockholm, Sweden.
authors.forename: Elin
authors.initials: E
authors.lastname: Lundström Belleza
authors.affiliation: Department of Applied Environmental Science, Stockholm University, Stockholm, Sweden.
authors.forename: Magnus
authors.initials: M
authors.lastname: Breitholtz
authors.affiliation: Department of Applied Environmental Science, Stockholm University, Stockholm, Sweden.
authors.forename: Elena
authors.initials: E
authors.lastname: Gorokhova
mesh_terms: D000818:Animals; D059001:Aquatic Organisms / Q000187:drug effects*; D003621:Daphnia / Q000187:drug effects; D015195:Drug Design; D016912:Levonorgestrel / Q000737:chemistry / Q000633:toxicity*; D008825:Miconazole / Q000737:chemistry / Q000633:toxicity*; D011398:Promethazine / Q000737:chemistry / Q000633:toxicity*; D018570:Risk Assessment; D014874:Water Pollutants, Chemical / Q000737:chemistry / Q000633:toxicity*
chemical_list: D014874:Water Pollutants, Chemical; D016912:Levonorgestrel; D008825:Miconazole; D011398:Promethazine